-
Novasep Upgrades API Manufacturing Facility
contractpharma
June 28, 2021
Novasep, a supplier of services and technologies for the life sciences industry, is investing $7.3 million at its Mourenx site in France to modernize the API manufacturing facility.
-
Global API market to value $300 billion by 2030
europeanpharmaceuticalreview
June 25, 2021
Researchers anticipate the growth of the aging population and rising investment in biologic drugs to promote the expansion of the global active pharmaceutical ingredient (API) market.
-
PLI scheme to help India become Aatmanirbhar in APIs; boost investments in high-value generics: ICRA
expresspharma
June 18, 2021
The production-linked incentive (PLI) schemes announced by the Government of India (GoI) for key raw materials such as bulk drugs and formulations, with a total incentive outlay of Rs. 210 billion will help the country become Aatmanirbhar.
-
Monosodium Phosphate 2-hydrate is now available with CEP
cphi-online
June 17, 2021
Dr. Paul Lohmann® recently received a CEP (Certificate of Suitability to the European Pharmacopoeia) for Monosodium Phosphate 2-hydrate, which enables a customer to register a drug in several countries in a cost-saving and simplified way.
-
Robust sales growth at Indian pharma companies expected in current FY on pandemic recovery, says Fitch
cphi-online
June 15, 2021
Drug categories impacted by travel restrictions expected to see higher sales levels in FY22
-
Entrinsic Bioscience Secures $49 million in Financing to Accelerate Development and Commercialization of Next Generation Functional Ingredients and Active Pharmaceutical Ingredients
firstwordpharma
June 11, 2021
entrinsic bioscience (EBS) announced that it has secured $49 million in non-dilutive growth capital from Jefferies Group LLC's subsidiary, Jefferies Funding LLC (Jefferies).
-
Novel microfluidic device could enhance crystalline drug safety
europeanpharmaceuticalreview
June 10, 2021
The continuous-flow microfluidic device allows scientists to assess crystalline API growth rates, shapes and structures to more quickly identify the best conditions for drug manufacturing.
-
Thermogelling nanoemulsion enhances drug loading of hydrophobic APIs
europeanpharmaceuticalreview
June 09, 2021
Using a new formulation technique, researchers were able to more than double drug loading of a hydrophobic active pharmaceutical ingredient in tablets. Thus, the new formulation method may lead to smaller pills delivering the same therapeutic benefit.
-
Onyx Scientific Receives Commercial API License for UK Facility
contractpharma
June 04, 2021
Onyx Scientific, a small molecule API contract development and manufacturing organization (CDMO) has received a commercial API license for its UK facility.
-
Biovectra Inc. Unveils New Logo and Brand
contractpharma
June 04, 2021
Biovectra Inc., a global contract development and manufacturing organization, has launched a new logo and brand to align with the growing company’s full suite of expertise and core values.